Frontispiece: Aza[6]helicene Platinum Complexes: Chirality Control of  cis–trans  Isomerism | Zendy

Mendola Daniele | Zendy; Saleh Nidal | Zendy; Vanthuyne Nicolas | Zendy; Roussel Christian | Zendy; Toupet Loïc | Zendy; Castiglione Franca | Zendy; Caronna Tullio | Zendy; Mele Andrea | Zendy; Crassous Jeanne | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Frontispiece: Aza[6]helicene Platinum Complexes: Chirality Control of cis–trans Isomerism

Author(s) -

Mendola Daniele,

Saleh Nidal,

Vanthuyne Nicolas,

Roussel Christian,

Toupet Loïc,

Castiglione Franca,

Caronna Tullio,

Mele Andrea,

Crassous Jeanne

Publication year - 2014

Publication title -

angewandte chemie international edition

Language(s) - English

Resource type - Reports

SCImago Journal Rank - 5.831

H-Index - 550

eISSN - 1521-3773

pISSN - 1433-7851

DOI - 10.1002/anie.201482371

Subject(s) - helicene , enantiopure drug , chirality (physics) , cis–trans isomerism , platinum , chemistry , ligand (biochemistry) , stereochemistry , molecule , enantioselective synthesis , organic chemistry , receptor , catalysis , physics , biochemistry , chiral symmetry , quantum mechanics , quark , nambu–jona lasinio model

In their Communication on page 5786 ff., J. Crassous and co‐workers show how cis – trans isomerism in [Pt II Cl 2 (4‐aza[6]helicene)PPh 3 ] is controlled by the racemic and enantiopure forms of the 4‐aza[6]helicene ligand.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research